BiotechTube
Home/Halozyme Therapeutics/Mark Snyder
MS

Mark Snyder

Chief Legal Officer

Halozyme Therapeutics

Therapeutic Areas

Drug DeliveryOncologyImmunologyEndocrinology

Halozyme Therapeutics Pipeline

DrugIndicationPhase
HYLENEX® recombinantHypodermoclysis and subcutaneous fluid administrationApproved
XYOSTED® CIIITestosterone replacement therapyApproved

Leadership Team at Halozyme Therapeutics

HT
Helen Torley
President and Chief Executive Officer
NL
Nicole LaBrosse
Chief Financial Officer
CC
Chase Coffman
President of Hypercon™
View full Halozyme Therapeutics profile